GSK Relocates R&D Center to Cambridge with Multi-Million Pound Investment

Pharmaceutical giant GSK is moving its research and development center to Cambridge, planning investments of nearly half a billion pounds in the university city, which is already home to AstraZeneca.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman10d ago

GSK verlegt R&D-Zentrum: Hunderte Millionen für den Forschungsstandort Cambridge

Der Pharmakonzern GSK verlegt sein Forschungszentrum in die Universitätsstadt, wo schon AstraZeneca sitzt. Er plant Investitionen für fast eine halbe Milliarde Pfund.

Read full article →

PERSPECTA

PERSPECTA

GSK Relocates R&D Center to Cambridge with Multi-Million Pound Investment

Sources

GSK verlegt R&D-Zentrum: Hunderte Millionen für den Forschungsstandort Cambridge

Related Stories

Stock Market Flashes Dot-Com Bubble Warning Signal

Qorvo Insiders File Amidst Merger Focus

AMD Challenges Nvidia with Bold New Move

Multiple Companies Report Q2 Earnings and Host Investor Calls

PERSPECTA